FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileShield Therapeutics plc
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
SHIEF
Shield Therapeutics plc Stock AnalysisComprehensive stock analysis for Shield Therapeutics plc (SHIEF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisSHIEF
SHIEF
Shield Therapeutics plc
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
SHIEF
  1. Home
  2. Stocks
  3. Shield Therapeutics plc

Shield Therapeutics plc

🇺🇸SHIEF•OTC

Shield Therapeutics plc

🇺🇸SHIEF•OTC
Market cap
$150.91M

Your view on SHIEF

Mkt Cap
$150.91M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Shield Therapeutics plc

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Anders Lundstrom
Headquarters
Northern Design Centre, Gateshead, GB
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Anders Lundstrom
Headquarters
Northern Design Centre, Gateshead, GB
Description

Shield Therapeutics plc, a specialty pharmaceutical company, engages in the development and commercialization of clinical stage pharmaceuticals to treat unmet medical needs. The company's lead product is Accrufer/Feraccru, a non-salt based oral therapy for the treatment of iron deficiency with or without anemia in adults.

It also develops PT20, a novel iron-based phosphate binder that has completed its Phase II pivotal study for the treatment of hyperphosphatemia in patients with chronic kidney disease. The company was founded in 2008 and is based in Gateshead, the United Kingdom.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Shield Therapeutics plc. Starting points for Shield Therapeutics plc: EPS -$0.0097, beta 1.96 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Shield Therapeutics plc. Shield Therapeutics plc does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Shield Therapeutics plc. Trailing twelve-month EPS for Shield Therapeutics plc stands at -$0.0097. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 20, 2026
More →

Earnings per share estimates

Per shareThis yearYear to Dec 2026Next yearYear to Dec 2027
Average estimate−$0.00$0.00
Lowest estimate−$0.01$0.00
Highest estimate−$0.00$0.00
Number of analysts11
A year ago−$0.021—
Growth vs a year ago——

1The year-ago figure includes one-time items, so growth is not shown.

Revenue estimates

TotalThis yearYear to Dec 2026Next yearYear to Dec 2027
Average estimate$44.78M$53.47M
Lowest estimate$40.44M$40.29M
Highest estimate$53.02M$78.33M
Number of analysts33
A year ago$50.81M—
Growth vs a year ago−11.9%—

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Shield Therapeutics plc. Shield Therapeutics plc has reported as a listed company since 2019. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold SHIEF19 companies
Compare SHIEF with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
BIOYFBioSyent Inc.HealthcareMedical - Pharmaceuticals$130.2M
GGBXFGreen Growth Brands Inc.HealthcareDrug Manufacturers - Specialty & Generic$2,061
GRUSFGrown Rogue International Inc.HealthcareDrug Manufacturers - Specialty & Generic$89.8M
HLTRFHLS Therapeutics Inc.HealthcareDrug Manufacturers - Specialty & Generic$105.1M
KNTPFKintor Pharmaceutical LimitedHealthcareBiotechnology$184.0M
LOVFFCannara Biotech Inc.HealthcareDrug Manufacturers - Specialty & Generic$125.5M
ORXOFOrexo AB (publ)HealthcareMedical - Pharmaceuticals$111.5M
More Drug Manufacturers - Specialty & Generic companies
TickerTypeCompanySectorExchangeMkt cap
CHALFChalice Brands Ltd.HealthcareOTC$6,660
CHHEChina Health Industries Holdings, Inc.HealthcareOTC$6,554
CHIZFChina Traditional Chinese Medicine Holdings Co. LimitedHealthcareOTC$1.4B
CHOOFChoom Holdings Inc.HealthcareOTC$4,670
CHSYFChina Medical System Holdings LimitedHealthcareOTC$3.3B
CL.CNCresco Labs Inc.HealthcareCNQ$565.2M
CLC.CNChristina Lake Cannabis Corp.HealthcareCNQ$9.9M
CLCFFChristina Lake Cannabis Corp.HealthcareOTC$6.2M
CLVRClever Leaves Holdings Inc.HealthcareOTC$702
CNFHFCanaFarma Hemp Products Corp.HealthcareOTC$19,561
CNGGFCann Group LimitedHealthcareOTC$4.4M
CNNACann American Corp.HealthcareOTC$1.1M
Open Comparable Analysis
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Shield Therapeutics plc. Coverage tracks Shield Therapeutics plc within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Shield Therapeutics plc.

SHIEF AnalysisWeak
Past
1
Growth
5
Health
1
Profit
1
Value
1